Role Overview 

We are seeking a Thought Leader Liaison to join Tenpoint Therapeutics to be a trusted medical marketing strategic partner to influential optometrists and ophthalmologists in supporting education, insight generation, speaker development and peer to peer engagement. This is an external facing role responsible for identifying, developing, and sustaining strategic relationships with thought leaders, including Presbyopia and emerging refractive therapies. You will play a critical role in shaping the Presbyopia ecosystem during market development and early commercialization, informing strategy across medical, marketing, and commercial teams.

This position covers the Great Lakes region. Willingness to travel up to 60%-70%.

Key Responsibilities 

Thought Leader Engagement & Development

• Identify, segment, and prioritize national, regional, and emerging thought leaders across OD and MD communities relevant to presbyopia
• Build long-term, trust-based relationships with high-influence clinicians, positioning the company as a credible scientific partner.
• Develop tailored engagement plans aligned to each thought leader’s influence, interests, and developmental stage.
• Serve as a consistent external presence for the company at congresses, advisory boards, speaker trainings, competitive intelligence and educational programs.

Speaker & Faculty Development

• Support the recruitment, training, and ongoing development of speaker bureau members.
• Coach speakers on effective scientific storytelling, data interpretation, and audience-specific messaging (within approved content).
• Senior Director to partner with Medical Affairs and Marketing to align faculty capabilities with educational needs across disease state, mechanism of action, and clinical integration.

Scientific Exchange & Insights

• Facilitate high-quality scientific discussions around clinical data, unmet needs, patient selection, and real-world adoption considerations.
• Gather and synthesize actionable insights from thought leaders to inform strategy, education, and future evidence generation.
• Provide feedback to internal stakeholders on emerging trends, objections, and opportunities within the refractive correction landscape.

Cross-Functional Collaboration

• Work closely with Medical Affairs, Marketing, Sales Leadership, and Training to ensure aligned, compliant execution.
• Contribute to advisory board planning, insight reports, and post-engagement readouts.
• Support congress strategy through faculty engagement, competitive intelligence, and on-site leadership presence.

Experience 

• Bachelor’s degree required
• Advanced degree (OD, MD, PharmD, PhD, MBA) a plus but not mandatory

• 8–12+ years of experience in Thought Leader development within pharmaceutical, biotech, or medical device environments, with significant external HCP engagement relevant to presbyopia.
• Prior experience in Medical Affairs, KOL Management, Thought Leader Engagement, Training, or Strategic Marketing strongly preferred
• Background in ophthalmology, optometry, refractive correction, or adjacent vision-care markets highly desirable.
• Proven ability to build and manage senior-level relationships with influential clinicians and academic leaders.
• Strong scientific and clinical fluency, enabling confident engagement with top-tier thought leaders and the ability to translate complex data into clear, credible dialogue.
• Demonstrated enterprise-level business acumen, with the ability to connect insights to broader business, educational, and market-shaping objectives.
• Strategic, adaptable mindset with comfort operating in ambiguous, evolving, and pre-launch/early-launch environments.
• High emotional intelligence, discretion, and credibility in sensitive scientific and peer-to-peer discussions.
• Currently have and maintain an unexpired driver’s license and maintain a satisfactory driving record.

Physical Requirements & Reasonable Accommodation

This position requires the ability to:

·       Travel to client sites, which may involve driving a car and/or utilizing other forms of transportation like planes, trains, or taxis. Must be able to navigate various environments, including office buildings, parking lots, outdoor settings, and transit centers.

·       Operate a computer and communicate effectively in a remote work environment.

·       Sit for extended periods, engage in video or phone meetings, and use standard office equipment.

·       Lift and transport materials up to 25 pounds occasionally.

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of the role.

 

Equal Opportunity Employer

We are an Equal Opportunity Employer. Consistent with applicable law, all qualified applicants will receive consideration for employment without regard to race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, Veteran status, or any other characteristic protected by applicable local laws, regulations and ordinances.

 

Salary and Benefits Information 

We know our people are the driving force behind the success of our mission and vision. That’s why we offer a competitive benefit package to attract the very best talent to our team and to take care of our employees and their families.​​​​​​​ Below is a snapshot of our U.S. benefits package for full-time employees. 

• Generous medical, dental, and vision health insurance plans 

• Flexible spending accounts for health and dependent care 

• Short-term, long-term, and life/AD&D insurance 

• Employee Assistance Program 

• 20 paid vacation days, 12 paid holidays, and 12 sick days 

• 401(k) Retirement Plan with 100% company match up to 4% and immediate vesting 

• Hybrid work options 

• Wellness Resources 

• Stock Options 

 

For more information, visit www.tenpointherapeutics.com and follow us on LinkedIn, X, and Instagram.

About Tenpoint Therapeutics

Tenpoint Therapeutics is a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye. Our pipeline includes paradigm-shifting therapeutics for ophthalmic indications with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy.

Our lead product, YUVEZZI™, is the first and only dual-agent eye drop for the treatment of presbyopia in adults and was approved by the FDA on January 28, 2026. Presbyopia, the gradual loss of near vision that typically begins around age 45, affects about two billion people globally and 128 million people in the U.S. YUVEZZI™ is expected to be broadly commercially available in the U.S. in Q2 2026.